MULTIDISCIPLINARY APPROACH IN THE TREATMENT OF PATIENTS WITH VALVULAR HEART DISEASE
Abstract
Highlights
This article presents the key components of a successful heart valve team model, including the optimal structure of a multidisciplinary team, the main features of the multidisciplinary approach, and the central role of the patient in choosing a personalized treatment strategy for patients with valvular heart disease. This review serves as a methodological framework for implementing a modern, evidence-based model of care for patients with valvular heart disease, aimed at optimizing diagnostics, selecting the appropriate method of valve defect correction, and improving long-term clinical outcomes.
Abstract
This document reflects the current challenges of the multidisciplinary approach in the treatment of patients with valvular heart disease, the basic principles of organizing a heart valve team in cardiac surgery centers, and the difficulties affecting the team's effectiveness. Despite the proven benefits of the multidisciplinary approach in managing patients with valvular pathology, the institutional inadequacy of this model persists within the national healthcare system. The existing organization of care is characterized by the fragmentation of cardiovascular surgeons, cardiologists, and interventional specialists, the absence of unified interaction protocols, and consequently creates uncertainty in selecting the optimal method of correction for patients with valvular heart disease. This discrepancy between global clinical guidelines and real-world clinical practice in our country highlights the necessity of conducting this review.
About the Authors
Elena S. OrganovaRussian Federation
Clinical Resident, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
Olga K. Kuzmina
Russian Federation
PhD, Research Assistant at the Laboratory of Valvular Heart Disease, Department of Heart and Vessel Surgery, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
Evgeny S. Osintsev
Russian Federation
Clinical Resident, Laboratory Assistant-Resercher at the Heart Defects Laboratory, Department of Heart and Vascular Surgery, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
Alexander N. Stasev
Russian Federation
PhD, MD, Cardiovascular Surgeon, Senior Researcher at the Heart Defects Laboratory, Department of Heart and Vascular Surgery, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
Olga L. Barbarash
Russian Federation
Academician of the Russian Academy of Sciences, PhD, MD, Professor, Director of the Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
References
1. Rogers MA, Tarantini G and Veulemans V (2023) Editorial: Case reports in heart valve disease: 2022. Front. Cardiovasc. Med. 10:1260522. doi: 10.3389/fcvm.2023.1260522
2. Bockeria, L. A. Cardiovascular Surgery – 2024. Diseases and Congenital Anomalies of the Circulatory System / L. A. Bockeria, E. B. Milievskaya, V. V. Pryanishnikov. – Moscow : Bakoulev National Medical Research Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, 2025. – 410 p.
3. Golukhova, E. Z. Report on Scientific and Medical Work of the Bakoulev National Medical Research Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, for 2021 and Development Prospects / E. Z. Golukhova // Bulletin of the Bakoulev Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences. Cardiovascular Diseases. – 2022. – Special Issue No. 23. – P. 12–111.
4. Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, Zühlke L, Prendergast BD. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021 Dec;18(12):853-864. doi: 10.1038/s41569-021-00570-z. Epub 2021 Jun 25. PMID: 34172950.
5. Santangelo G., Bursi F., Faggiano A., et al. The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management // J Clin Med. 2023. Vol. 12, N 6. P. 2178. doi: 10.3390/jcm12062178
6. Dren’ EV, Lyapina IN, Pecherina TB, Barbarash OL. Phenotype of a patient with valvular heart disease: literature review. CardioSomatics. 2023;14(4):269–282. DOI: https://doi.org/10.17816/CS601825
7. Kuzmina O.K., Stasev A.N., Tsenter I.M., Evtushenko A.V., Barbarash O.L., Barbarash L.S. Changes in the portrait of patients with acquired mitral and aortic valve disease before implantation of bioprosthetic heart valves. Complex Issues of Cardiovascular Diseases. 2024;13(4): 6-12. DOI: 10.17802/2306-1278-2024-13-4-6-12
8. Valvular heart disease: the next cardiac epidemic / d'Arcy J.L. and others // Heart. 2011. Vol. 97, №2. P. 91-93.14. P. 1156–1169. doi: 10.1161/CIRCULATIONAHA.119.041080
9. Skopin I.I., Otarov A.M. Preoperative risk factors in elderly patients undergoing aortic valve
10. replacement. Byulleten’ Nauchnogo Tsentra Serdechno-Sosudistoy Khirurgii imeni A.N. Bakuleva RAMN (The Bulletin of Bakoulev Center. Cardiovascular Diseases, Russian journal). 2017; 18 (3): 243–55 (in Russ.). DOI:10.24022/1810-0694-2017-18-3-243–255
11. Semenova E.I., Zheleznev S.I., Semenov I.I., et al. Heart Valve Prosthesis in Elderly Patients. Risk Factors: Associated Diseases // Siberian Journal of Clinical and Experimental Medicine. 2007. T 22, №3. 97-100
12. Charalampopoulos A, Lewis R, Hickey P, Durrington C, Elliot C, Condliffe R, Sabroe I, Kiely DG. Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease. Front Med (Lausanne). 2018 Jun 6;5:174. doi: 10.3389/fmed.2018.00174. PMID: 29928642; PMCID: PMC5997828
13. Thierry Mesana, Heart Teams for Treatment of Cardiovascular Disease. Springer Nature Switzerland AG 2019, ISBN 978-3-030-19124-5, 158р
14. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes. A Report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. Journal of the American college of cardiology. JACC VOL. 64, NO. 24, 2014 http://dx.doi.org/10.1016/j.jacc.2014.09.017
15. AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions. JACC VOL. 64, NO. 17, 2014. http://dx.doi.org/10.1016/j.jacc.2014.07.012/
16. Aleksandrova SA, Apkhanova TV, Aronov DM, et al. Mitral regurgitation. Clinical guidelines 2024. Russian Journal of Thoracic and Cardiovascular Surgery. 2025; 67 (4): 474–523. (In Russ.). DOI: 10.24022/0236-2791-2025-67-4-474-523.
17. Aortic Stenosis: Clinical Guidelines of the Russian Federation 2025 / Russian Society of Cardiology [et al.]. – Moscow: Ministry of Health of the Russian Federation, 2025. – URL: https://cr.minzdrav.gov.ru/ (cited: 28.03.2026)
18. Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, Ajmone Marsan N, Barili F, Bonaros N, Cosyns B, De Paulis R, Gamra H, Jahangiri M, Jeppsson A, Klautz RJM, Mores B, Pérez-David E, Pöss J, Prendergast BD, Rocca B, Rossello X, Suzuki M, Thiele H, Tribouilloy CM, Wojakowski W; ESC/EACTS Scientific Document Group. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025 Aug 29:ehaf194. doi: 10.1093/eurheartj/ehaf194. Epub ahead of print. PMID: 40878295
19. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17. Erratum in: Circulation. 2021 Feb 2;143(5):e228. doi: 10.1161/CIR.0000000000000960. Erratum in: Circulation. 2021 Mar 9;143(10):e784. doi: 10.1161/CIR.0000000000000966. PMID: 33332149.
20. Kesson E.M., Allardice G.M., George W.D., Burns H.J.G., Morrison D.S. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344:e2718
21. Hickman L.D., Phillips J.L., Newton P.J., Halcomb E.J., Al Abed N., Davidson P.M. Multidisciplinary team interventions to optimise health outcomes for older people in acute care settings: a systematic review. Arch Gerontol Geriatr. 2015;61:322-329
22. Jones D.R., Chew D.P., Horsfall M.J., et al. Multidisciplinary transcatheter aortic valve replacement heart team programme improves mortality in aortic stenosis. Open Heart. 2019;6:e000983
23. AUSTIN WO, ADAMS FH, HOLVE L. The cardiac team; an introduction to a symposium on congenital heart disease. Calif Med. 1957 Mar;86(3):161. PMID: 13404513; PMCID: PMC1512022
24. King S.B. 3rd, Barnhart H.X., Kosinski A.S., Weintraub W.S., Lembo N.J., Petersen J.Y. et al. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am. J. Cardiol. 1997; 79 (11): 1453–9. DOI: 10.1016/s0002-9149(97)00170-7
25. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360: 961– 72
26. Head S.J., Holmes D.R. Jr., Mack M.J., Serruys P.W., Mohr F.W., Morice M.C. et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc. Interv. 2012; 5 (6): 618–25. DOI: 10.1016/j.jcin.2012.02.013
27. Lceon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21;363(17):1597-607. doi: 10.1056/NEJMoa1008232. Epub 2010 Sep 22. PMID: 20961243
28. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5. PMID: 21639811
29. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391. PMID: 28886619
30. Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, et al. ESC Working Group on Valvular Heart Disease Position Paper–heart valve clinics: organization, structure, and experiences. Eur Heart J 2013;34:1597–606. https://doi.org/10.1093/ eurheartj/ehs443
31. Geirsson A, Ahlsson A, Franco-Cereceda A, Fuglsang S, Gunn J, Hansson EC, et al. Hospital volumes and later year of operation correlates with better outcomes in acute Type A aortic dissection. Eur J Cardiothorac Surg 2018;53:276–81. https://doi.org/10.1093/ejcts/ezx231
32. Batchelor WB, Anwaruddin S, Wang DD, Perpetua EM, Krishnaswami A, Velagapudi P, Wyman JF, Fullerton D, Keegan P, Phillips A, Ross L, Maini B, Bernacki G, Panjrath GS, Lee J, Geske JB, Welt F, Thakker PD, Deswal A, Park K, Mack MJ, Leon M, Lewis S, Holmes D. The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges. JACC Adv. 2023 Jan 11;2(1):100160. doi: 10.1016/j.jacadv.2022.100160. PMID: 38939019; PMCID: PMC11198656.
33. Mesana T, Rodger N, Sherrard H. Heart Teams: A New Paradigm in Health Care. Can J Cardiol. 2018 Jul;34(7):815-818. doi: 10.1016/j.cjca.2018.02.028. Epub 2018 Mar 2. PMID: 29960610.
34. Agricola E, Ancona F, Brochet E, Donal E, Dweck M, Faletra F, Lancellotti P, Mahmoud-Elsayed H, Marsan NA, Maurovich-Hovart P, Monaghan M, Ribeiro J, Sade LE, Swaans M, Von Bardeleben RS, Wunderlich N, Zamorano JL, Popescu BA, Cosyns B, Edvardsen T. The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2021;22:471479
35. Marcoff L, Gillam LD. Role of the Imager in Transcatheter Mitral Valve Repair. Curr Cardiol Rep. 2020 Aug 9;22(10):120. doi: 10.1007/s11886-020-01362-6. PMID: 32772221
36. O.L. Barbarash, V.V. Kashtalap, R.S. Tarasov Multidisciplinary approach in the treatment of a cardiological patient, Kemerovo: Primula, 2024, 208p ISBN 978-5-904430-77-1
37. Forcillo J, Condado JF, Ko YA, Yuan M, Binongo JN, Ndubisi NM, Kelly JJ, Babaliaros V, Guyton RA, Devireddy C, Leshnower BG, Stewart JP, Perrault LP, Khairy P, Thourani VH. Assessment of Commonly Used Frailty Markers for High- and Extreme-Risk Patients Undergoing Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2017 Dec;104(6):1939-1946. doi: 10.1016/j.athoracsur.2017.05.067. Epub 2017 Sep 21. PMID: 28942076.
38. Krivoshapova KE, Vegner EA, Barbarash OL. Phenomenon of frailty in patients undergoing cardiac surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2020;13(1):48 55. (In Russ.) https://doi.org/10.17116/kardio20201301148
39. Yanagisawa R, Tanaka M, Yashima F, Arai T, Kohno T, Shimizu H, Fukuda K, Naganuma T, Mizutani K, Araki M, Tada N, Yamanaka F, Shirai S, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Yamamoto M, Hayashida K. Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve Implantation. Am J Cardiol. 2018 Sep 1;122(5):844-850. doi: 10.1016/j.amjcard.2018.05.026. Epub 2018 Jun 2. PMID: 30072128.
40. Siontis GCM, Overtchouk P, Cahill TJ, Modine T, Prendergast B, Praz F, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treat-ment of symptomatic
41. severe aortic stenosis: an updated meta-analysis. Eur Heart J 2019;40:3143–53. https://doi.org/10.1093/eurheartj/ehz275
42. Ahmad Y, Howard JP, Arnold AD, Madhavan MV, Cook CM, Alu M, et al. Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. Eur Heart J 2023;44:836–52. https://doi.org/10.1093/eurheartj/ehac642
43. Yoon SH, Bleiziffer S, De Backer O, Delgado V, Arai T, Ziegelmueller J, et al. Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. J Am Coll Cardiol 2017;69:2579–89. https://doi.org/10.1016/j.jacc.2017.03.017
44. Smith WT 4th, Ferguson TB Jr, Ryan T, Landolfo CK, Peterson ED. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol. 2004 Sep 15;44(6):1241-7. doi: 10.1016/j.jacc.2004.06.031. PMID: 15364326.
45. Goldstone AB, Chiu P, Baiocchi M, Lingala B, Patrick WL, Fischbein MP, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med 2017;377:1847–57. https://doi.org/10.1056/NEJMoa1613792
46. Landers, D, Anderson, M, Kaple, R. et al. The Impact of the Multidisciplinary Team on the Volume of Complex Cardiovascular Interventions. JACC Adv. 2025 Aug, 4 (8) .https://doi.org/10.1016/j.jacadv.2025.101967
47. Lauck S.B., Lewis K.B., Borregaard B., de Sousa I. What is the right decision for me; integrating patient perspectives through shared decision-making for valvular heart disease therapy. Can J Cardiol. 2021;37:1054-1063.
48. Tsaroev B. S., Bogachev-¬ Prokofiev A. V., Zheleznev S. I., Sharifulin R. M., Zalesov A. S., Chernyavsky A. M. Transcatheter and surgical aortic valve replacement in patients at low surgical risk. Review of major studies. Russian Journal of Cardiology. 2024;29(12):6188. doi: 10.15829/1560-4071-2024-6188. EDN ZHJVOF
49. Arnold S.V., Spertus J.A., Lei Y., et al. How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial. J Am Coll Cardiol. 2016;68:1868-1877.
50. M.S. Rusakova, “Possibilities and Limitations of the Typological Approach in Team Building”, Discussion, No. 10 (40), 2013, 172-178.
51. Rhee J, Parent D, Basu A. The influence of personality and ability on undergraduate teamwork and team performance. Springerplus. 2013 Dec;2(1):16. doi: 10.1186/2193-1801-2-16. Epub 2013 Jan 19. PMID: 23420685; PMCID: PMC3568485.
52. McCrae, R. R. (2011). Personality theories for the 21st century. Teaching of Psychology, 38(3), 209–214.
53. Neuman GA, Wright J. Team effectiveness: beyond skills and cognitive ability. J Appl Psychol. 1999 Jun;84(3):376-89. doi: 10.1037/0021-9010.84.3.376. PMID: 10380418.
54. Felps W, Mitchell TR, Byington E: How, when, and why bad apples spoil the barrel: negative group members and dysfunctional groups. Res Organ Behav 2006, 27: 175-222.
55. Barrick MR, Stewart GL, Neubert MJ, Mount MK: Relating member ability and personality to work-team processes and team effectiveness. J Appl Psychol 1998, 83(3):377-391. 10.1037/0021-9010.83.3.377
56.
Review
For citations:
Organova E.S., Kuzmina O.K., Osintsev E.S., Stasev A.N., Barbarash O.L. MULTIDISCIPLINARY APPROACH IN THE TREATMENT OF PATIENTS WITH VALVULAR HEART DISEASE. Complex Issues of Cardiovascular Diseases. 2026;15(3):143-155. (In Russ.)
JATS XML

































